Genetic Confirmation of Monogenic Familial Hypercholesterolemia Advises a More Intensive Lipid-Lowering Approach

Affiliations

¹ Internal Medicine Unit, Fundación Alcorcon University Hospital, Rey Juan Carlos University, Madrid, Spain.
² Head Lipid Clinic and Lipid Research Group, Miguel Servet University Hospital, Instituto de Investigación Sanitaria Aragon, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Zaragoza, Spain.
³ Lipids and Arteriosclerosis Research Unit, Sant Joan University Hospital, Internal Medicine Department, Institut d'Investigació Sanitària Pere Virgili, Rovira I Virgili University, Catalonia, Spain.

Comment

Carlos Guijarro et al. JAMA Cardiol. 2020.

. 2020 Dec 1;5(12):1452-1453.

doi: 10.1001/jamacardio.2020.4114.

¹ Internal Medicine Unit, Fundación Alcorcon University Hospital, Rey Juan Carlos University, Madrid, Spain.
² Head Lipid Clinic and Lipid Research Group, Miguel Servet University Hospital, Instituto de Investigación Sanitaria Aragon, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Zaragoza, Spain.
³ Lipids and Arteriosclerosis Research Unit, Sant Joan University Hospital, Internal Medicine Department, Institut d'Investigació Sanitària Pere Virgili, Rovira I Virgili University, Catalonia, Spain.

No abstract available

Comment in

Genetic Confirmation of Monogenic Familial Hypercholesterolemia Advises a More Intensive Lipid-Lowering Approach-Reply.
Trinder M, Brunham LR. Trinder M, et al. JAMA Cardiol. 2020 Dec 1;5(12):1453. doi: 10.1001/jamacardio.2020.4120. JAMA Cardiol. 2020. PMID: 32936211 No abstract available.

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.
Trinder M, Francis GA, Brunham LR. Trinder M, et al. JAMA Cardiol. 2020 Apr 1;5(4):390-399. doi: 10.1001/jamacardio.2019.5954. JAMA Cardiol. 2020. PMID: 32049305 Free PMC article.